Oral Tolerance to Cancer Can Be Abrogated by T Regulatory Cell Inhibition

Oral administration of tumour cells induces an immune hypo-responsiveness known as oral tolerance. We have previously shown that oral tolerance to a cancer is tumour antigen specific, non-cross-reactive and confers a tumour growth advantage. We investigated the utilisation of regulatory T cell (Treg...

Descripción completa

Detalles Bibliográficos
Autores principales: Whelan, Maria C., Casey, Garrett, Larkin, John O., Guinn, Barbara-ann, O'Sullivan, Gerald C., Tangney, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022586/
https://www.ncbi.nlm.nih.gov/pubmed/24832130
http://dx.doi.org/10.1371/journal.pone.0097602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022586/
https://www.ncbi.nlm.nih.gov/pubmed/24832130
http://dx.doi.org/10.1371/journal.pone.0097602

Ejemplares similares